0000899243-18-028966.txt : 20181114 0000899243-18-028966.hdr.sgml : 20181114 20181114210021 ACCESSION NUMBER: 0000899243-18-028966 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181112 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: North Michael Paul CENTRAL INDEX KEY: 0001689925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 181185800 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY, SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-12 0 0000896262 AMEDISYS INC AMED 0001689925 North Michael Paul 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Information Officer Common Stock 2018-11-12 4 M 0 2264 32.56 A 23767 D Common Stock 2018-11-12 4 S 0 2264 119.30 D 21503 D Common Stock 2018-11-13 4 M 0 100 32.56 A 21603 D Common Stock 2018-11-13 4 S 0 100 118.06 D 21503 D Common Stock 2018-11-14 4 M 0 3261 32.56 A 24764 D Common Stock 2018-11-14 4 S 0 3261 116.36 D 21503 D Common Stock 391 I Through 401(k) Plan Stock Option (right to buy) 32.56 2018-11-12 4 M 0 2264 0.00 D 2025-06-02 Common Stock 2264 9236 D Stock Option (right to buy) 32.56 2018-11-13 4 M 0 100 0.00 D 2025-06-02 Common Stock 100 9136 D Stock Option (right to buy) 32.56 2018-11-14 4 M 0 3261 0.00 D 2025-06-02 Common Stock 3261 5875 D The total amount of shares beneficially owned includes 761 shares held in an employee stock purchase plan account. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.00 to $119.80 inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.28 to $116.39 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The information in this report is based on a plan statement dated as of September 30, 2018. On June 2, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The stock options are subject to time-based vesting conditions. 5,625 of the options vested on each of June 2, 2016, June 2, 2017 and June 2, 2018, and the remaining 5,625 options will vest on June 2, 2019, provided that the reporting person remains continuously employed by the Issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2018-11-14